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component summary scores and clinical variables, at
baseline, week 2, and week 6, were observed. A similar
trend was observed between SF-12 and clinical variable
change scores at week 2 and week 6.
CONCLUSION: The SF-12 is a psychometrically sound
tool for the assessment of HQL in osteoarthritis patients.
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OBJECTIVE: To compare the responsiveness of arthritis-
specific and generic health outcome measures in relation
to changes in rheumatoid arthritis (RA) severity and to
treatment. Clinical trial patients (n = 315) were assessed
at baseline and again after two weeks of treatment. Crite-
rion measures of severity change included physician glo-
bal assessment, duration of morning stiffness, number of
tender and swelling joints, functional capacity classifica-
tion, visual analogue pain scale, and patient global assess-
ment.
METHODS: The responsiveness of each disease-specific
and generic measure was estimated independently using
the relative validity (RV) methodology, which compares
F-ratios for average changes in specific and generic mea-
sures across groups differing in the amount of change in
the criterion variables and treatment. RV coefficients esti-
mate how each measure responded, relative to the best
measure (RV = 1.0). An RA-specific measure was based
on the Health Assessment Questionnaire (HAQ). Generic
measures included eight scales, two summary measures,
and an arthritis-specific health index (ASHI) scored from
the SF-36 Health Survey.
RESULTS: The SF-36 ASHI was most valid (RV = 1.0)
for 4 of the 8 criteria. The SF-36 bodily pain (BP) scale
was most valid (RV = 1.0) for 2 of the 8 criteria, includ-
ing treatment. The SF-36 vitality scale was most valid
(RV = 1.0) for 1 of the 8 criteria. SF-36 scales measuring
physical health were consistently more valid (RV > .30)
than scales measuring mental health (RV < .20). The
HAQ was highly valid for 2 of the 8 criteria (RV = .89-
.92) and responded moderately well to 4 other criteria
(RV = .28-.49).
CONCLUSION: The responsiveness of the arthritis-spe-
cific scoring of the SF-36 health profile to changes in se-
verity of rheumatoid arthritis was equal to or better than
the generically scored SF-36 health profile and disease-
specific Health Assessment Questionnaire (HAQ).
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OBJECTIVE: To compare the responsiveness of arthritis-
specific and generic health outcome measures in relation
to changes in the severity of osteoarthritis (OA). Clinical
trial patients (n = 1,177) were assessed at baseline and
again after two weeks of treatment. Criterion measures of
change in severity included physician global assessment,
knee pain on weight bearing, knee pain on motion, and
patient global assessment.
METHODS: The responsiveness of each disease-specific
and generic measure was estimated independently using
the relative validity (RV) methodology, which compares
F-ratios for average changes in specific and generic mea-
sures across groups differing in the amount of change in
the criterion variables. RV coefficients estimate how each
measure responded, relative to the best measure (RV =
1.0). OA-specific measures were based on the WOMAC
questionnaire. Generic outcome measures included eight
scales, physical and mental summary measures, and ar-
thritis-specific health index (ASHI) scored from the SF-36
Health Survey.
RESULTS: The SF-36 ASHI was most valid (RV = 1.0)
for 3 of the 4 clinical criteria, followed by the SF-36
bodily pain (BP) scale (RV = .74-.98) for two of the clin-
ical criterion. SF-36 physical health (physical functioning,
role physical, physical summary) and social functioning
scales were consistently more valid (RV > .30) than the
SF-36 mental health scales (RV < .30). The WOMAC to-
tal scale score was more valid (RV = .91-1.0) than any of
the three WOMAC subscales. With the exception of the
SF-36 ASHI and BP scales, the WOMAC pain (RV =
.80-.83), physical functioning (RV = .76-.95), and stiff-
ness (RV = .61-.70) subscales were more valid than SF-36
scales.
CONCLUSION: This study replicates results from previ-
ous studies showing that arthritis-specific scoring of the
generic SF-36 health profile increases its responsiveness
to changes in arthritis severity.
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Key components of preventive health care for middle-
aged and older women include evaluating the risk for os-
teoporosis and coronary artery disease, considering hor-
